Cyclic vomiting syndrome …

Shannon Babineau MD

General Child Neurology

Updated 09.04.2023
Released 10.20.1998
Expires For CME 09.04.2026

Cyclic vomiting syndrome

Author: Shannon Babineau MD

See Contributor Disclosures

Editor: Bernard L Maria MD

Cyclic vomiting syndrome

In This Article

Quick Link

Introduction

Overview

Cyclic vomiting syndrome is considered one of the disorders of gut-brain interaction and migraine variants. It is typified by stereotyped intense bouts of vomiting, at least four times per hour, lasting for hours to days followed by stretches of wellness. It has been recognized in children for over 100 years, and it is being recognized as a condition that affects adults as well. Its pathophysiology is still not well understood; however, identification of autonomic and mitochondrial dysfunction has helped towards a better understanding.

Key points

	• Cyclic vomiting syndrome should be considered in any person with stereotyped episodes of vomiting with interspersed wellness.
	• Early consideration of the diagnosis of cyclic vomiting syndrome can minimize time to diagnosis and use of low-yield testing.
	• Cyclic vomiting syndrome is a variant of migraine and management is based on typical migraine treatment paradigms.

Historical note and terminology

Cyclic vomiting was first described by Dr. Samuel Gee in 1882. He wrote: “These cases seem to be all of the same kind, their characteristic being fits of vomiting, which recur after intervals of uncertain length. The intervals themselves are free from signs of disease.” His observations were later included into the definition of “the periodic syndrome of childhood” described by Wyllie and Schlesinger in 1933. They described young children with stereotyped episodes of pyrexia, headache, vomiting, and abdominal pain that persisted as migraine in the older child. Eventually “the periodic syndrome” was parsed into benign paroxysmal torticollis of infancy, benign paroxysmal vertigo of childhood, cyclic vomiting syndrome, and abdominal migraine. These conditions are now identified as migraine precursors or variants. Most children with these conditions have a family history of migraine or the child him/herself will develop migraine later in life. There seems to be overlap in underlying pathophysiology as well as in potential treatment modalities linking these conditions with each other and with migraine. The first diagnostic criteria for cyclic vomiting syndrome were proposed in 1994 and the most recent criteria for children were published in 2008 by the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Consensus Statement (20). The Rome Foundation Rome III criteria and the International Classification of Headache Disorders version 3 beta also offer criteria.

Clinical manifestations

Presentation and course

The most commonly described form of cyclic vomiting syndrome is of childhood onset typically starting around age 4 to 5 years. The attacks are discrete and have a clear start and end and typically follow a pattern of prodromal phase, vomiting phase, and then recovery phase.

Similar to migraine, there can be a 1-to-2-hour prodrome of nausea, fatigue, anorexia, and pallor that can also rarely be associated with aura. This period is followed by the vomiting phase with very high frequency vomiting. During this time vomiting occurs at least four times an hour at peak but can be much higher, with rates of 70 times an hour reported. There are few conditions that can match this level of vomiting and it is this high frequency that can distinguish cyclic vomiting syndrome from other conditions. Emesis usually begins during the middle of the night or in the early morning. The vomiting phase typically lasts 24 hours. The recovery phase is typified by sleep and the child often awakens from sleep feeling well and back to normal. Frequency of attacks varies; the average frequency of attacks is 1 to 36 times/year (mean eight times) (22; 14).

There seem to be subgroups of those with cyclic vomiting that may point to different etiologies and treatment paradigms. This is best outlined in a paper by Li in 2018 (20). There is a migraine subgroup, which is the great majority of patients, who have a personal or family history of migraine and respond well to anti-migraine therapies. There is a “Sato variant” with associated hypertension and extreme sleepiness thought to be mediated by the hypothalamic-pituitary-adrenal axis. In this subgroup, attacks tend to be longer and more severe. Mitochondrial dysfunction can underly some with cyclic vomiting syndrome, mitochondrial DNA polymorphisms have been identified, and there are children who respond well to mitochondrial supplements like coenzyme q10 and carnitine.

There is also an adult-onset form of cyclic vomiting syndrome that is being increasingly recognized. The vomiting episodes start at age 18 years or later. The typical age of onset is 21 years, with the diagnosis often being made 8 to 10 years later. The Rome IV diagnostic criteria are used for adults and are similar to the pediatric criteria (33). There does not seem to be a significant difference in triggers, comorbid conditions, migraine history, or response to treatment in adult and pediatric cyclic vomiting syndrome. The only difference is that pediatric patients are more likely to be female (16).

Table 1. Diagnostic Criteria of Cyclic Vomiting Syndrome*

(1) At least five attacks in any interval, or a minimum of three attacks during a 6-month period
(2) Episodic attacks of intense nausea and vomiting lasting 1 hour to 10 days and occurring at least 1 week apart
(3) Stereotypical pattern and symptoms in the individual patient
(4) Vomiting during attacks occurs at least four times per hour for at least 1 hour
(5) Return to baseline health between episodes

*All of the criteria must be met to meet this consensus definition of cyclic vomiting syndrome.

(20)

Prognosis and complications

The complications from cyclic vomiting syndrome are related to the profound vomiting. Esophagitis and esophageal tears can occur from the trauma of repetitive vomiting. In addition, severe dehydration can occur with associated metabolic derangements. The majority of patients will require a visit to the emergency room for intravenous therapy at least once, with an average of 10 visits in one study (35). At least 50% of children have had at least one overnight admission to the hospital for cyclic vomiting syndrome (09). A study found that two thirds of emergency room visits for cyclic vomiting syndrome result in hospitalization (01). Arriving in the emergency room more than 24 hours after symptom onset, male sex, younger age (younger than 10 years old), and delayed timing before the first dose of antiemetics in the emergency room were predictors for admission.

In children it is reported that the cyclic vomiting syndrome lasts an average of five years and will resolve in later childhood in 96% of patients (14). There is a strong link between cyclic vomiting syndrome and migraine, with 79% of patients developing migraine during or after cyclic vomiting syndrome onset, typically around age six years (24).

Clinical vignette

This clinical vignette is based on a real patient and some of the information has been changed for a more straightforward presentation.

The patient is now a 5-year-old boy who started having episodes of vomiting around one year of age. Each episode would start with him becoming pale and listless. Within two hours he would start to vomit, usually about five to six times per hour. The intense vomiting would continue for 3 to 4 hours and then would slow down to one to two times per hour. His attacks usually lasted for 3 to 4 days and often by the second day he was significantly dehydrated. He usually required admission to the hospital by the second day, where he was managed with intravenous fluids, lorazepam, and ondansetron. He had an evaluation including upper gastrointestinal series and endoscopy and in addition MRI of the brain, continuous 24-hour EEG, and metabolic evaluation including spinal tap and bloodwork. There were no abnormalities found. The patient has had two seizures thought to be secondary to hyponatremia at the time of the events (sodium in low 120s). After recovery from the events, he was well except for minor speech delay. These events occurred about five times a year. He was initially tried on cyproheptadine and then eventually propranolol. With the addition of carnitine and coenzyme Q10 to the propranolol his events reduced in frequency to twice a year and he was able to be managed at home. The cyclic vomiting has continued.

This case has several typical features of cyclic vomiting syndrome: the events are stereotyped and predictable; the patient becomes profoundly dehydrated requiring hospitalization with complications from the dehydration including hyponatremic seizures. Also, not uncommonly and subtyped as cyclic vomiting syndrome plus, between events he does have some developmental delay. This patient had thousands of dollars’ worth of testing done, which is not uncommon. The mean cost of evaluation for cyclic vomiting per child is approximately $6000 (23). The additional testing is not unwarranted in this child given his early age at presentation as well as his seizures. His response to typical migraine prevention is not unusual.

Biological basis

Etiology and pathogenesis

The pathophysiology of cyclic vomiting syndrome is unclear. Given the link between migraine and cyclic vomiting it is assumed that there are similarities in underlying cause. The initial link between migraine and cyclic vomiting syndrome was because of the high rates of personal (40% to 46%) and family history (28% to 82%) of migraine in those with cyclic vomiting syndrome (17). Migraine and cyclic vomiting often share common triggers including stress, change in sleep patterns, and certain foods. There also seems to be some overlap in the presumed mechanisms behind migraine and cyclic vomiting syndrome including mitochondrial dysfunction and autonomic dysfunction.

Mitochondrial dysfunction was initially implicated in the pathophysiology of cyclic vomiting syndrome because of the maternal inheritance pattern and abnormalities seen on laboratory studies performed during attacks, including lactic acidosis and urine organic acid patterns consistent with energy failure (07). Testing of mitochondrial DNA has revealed at least two polymorphisms that are highly correlated with pediatric cyclic vomiting syndrome. The 16519T polymorphism is six times more common in children with cyclic vomiting syndrome versus controls, and in those with the 3010A polymorphism who also have the 16519T polymorphism the likelihood of cyclic vomiting syndrome is increased by 17 times (41). Interestingly, these polymorphisms are not significant in adult-onset cyclic vomiting syndrome (39), although they have been found to be significantly associated in adult patients with migraine (41). In a study of whole exome sequencing in those with cyclic vomiting syndrome, the candidate genes identified were either involved with energy metabolism or positive ion transport (05).

The dysfunction of the autonomic nervous system in cyclic vomiting syndrome has been noted since the late 1990s when two groups of investigators noted increased sympathetic cardiovascular tone in patients with cyclic vomiting syndrome (29; 34). It is thought that hypersensitivity of the autonomic nervous system to emetic signals is what predisposes some to such abnormal vomiting reaction. In a natural history study following children with cyclic vomiting syndrome, 40% were found to have symptoms of dysautonomia (dizziness, nausea, fatigue, syncope) in adolescence (12). In autonomic testing of adult patients with cyclic vomiting syndrome 90% of the patients were impaired with postural orthostatic tachycardia syndrome (POTS) (35%) or sudomotor dysfunction (90%) (35).

Seventy-five patients with cyclic vomiting syndrome were compared to controls with next-generation genomic sequencing and there was a significantly associated mutation in the RYR2 gene. This gene codes a calcium channel that is used for excitation contraction coupling in the heart and is also found in the autonomic nervous system and seems to be part of a stress response (18). Anecdotally, propranolol can help treat cyclic vomiting syndrome patients with this mutation (21).

A review of a small number of adult and pediatric patients with cyclic vomiting syndrome noted that clinically the circadian nature of attacks, autonomic dysfunction, as well as objective findings on PET imaging implicate the hypothalamus as well as the insula (30). Insular involvement was echoed in a second study released that used functional MRI (10).

The connection between chronic marijuana use and a cyclic vomiting-like syndrome (cannabinoid hyperemesis syndrome) has also raised a question about the role of the endogenous cannabinoid system. This system is known to play a role in nausea and vomiting and it is possible that an imbalance in this system could also play a role in cyclic vomiting syndrome (27; 38). Polymorphisms in the genes for cannabinoid receptor type 1 and mu-opioid receptor, part of the endogenous cannabinoid system, have been shown to be associated with increased risk of cyclic vomiting syndrome whereas other polymorphisms appear protective against it (40).

Differential diagnosis

A single episode of recurrent vomiting is indistinguishable from many acute gastrointestinal illnesses. Until a temporal and intensity pattern is established leading to the clinical suspicion of cyclic vomiting syndrome, it is important to rule out many other disorders. In essence, cyclic vomiting syndrome is a diagnosis of exclusion. See below table for full differential list.

Panayiotopoulos syndrome is an epilepsy syndrome that occurs most frequently in the 3- to 6-year-old age range. It is typified by autonomic dysfunction as the ictal phenomenon. The majority of patients have vomiting as part of the seizure or at least nausea/retching. This syndrome is prone to be prolonged with up to half of patients having seizures that last for more than 30 minutes. Most events will progress to more typically recognized seizures with tonic or clonic activity. Often the events will start during sleep. In more than 90% of patients there will be interictal findings on EEG of either multifocal sharps or occipital spikes (26).

Abdominal migraine is often used interchangeably with cyclic vomiting syndrome. Although these conditions can overlap, there are separate diagnostic criteria. The hallmark of abdominal migraine is the periumbilical pain whereas the hallmark of cyclic vomiting syndrome is profound vomiting. There can certainly be vomiting with abdominal migraine; however, it does not meet the high frequency that is seen with cyclic vomiting syndrome. In cyclic vomiting syndrome there may be associated abdominal pain; however, the vomiting is a much more significant component.

Cannabinoid hyperemesis syndrome is recognized more in adults with cyclic vomiting but should also be questioned in teenage patients. It is typified by chronic marijuana use for years (typically daily or near daily for more than 1 year) and paroxysmal episodes of profound vomiting. This vomiting is usually improved with a hot shower, so there becomes a compulsive bathing that occurs during episodes. Symptoms should resolve with cessation of marijuana use. Although criteria for this syndrome was put forth in the Rome IV guidelines (32), it is not always a straightforward diagnosis. Many patients with cyclic vomiting syndrome use cannabis regularly, 41% in a study, and up to 21% are using regularly many times per week (36). Many patients find cannabis helpful in management of cyclic vomiting syndrome symptoms. In this study, even though 86% of cannabis users reported abstaining from cannabis use for at least one month, only one patient reported resolution of cyclic vomiting syndrome episodes after cannabis cessation.

A list of differential diagnostic possibilities is listed in Table 2.

Table 2. Differential Diagnosis of Cyclic Vomiting Syndrome

Neurologic
	• Epilepsy
		- Panayiotopoulos syndrome - Simple partial seizures - Complex partial seizures
	• Hydrocephalus • Subdural hematomas or effusions • CNS neoplasms
		- Posterior fossa tumors - Temporal lobe astrocytomas
	• Autonomic hyperreactivity • Familial dysautonomia • Mitochondrial disorder
Gastrointestinal or hepatobiliary
	• Gastroesophageal reflux • Lactose intolerance • Irritable bowel syndrome • Constipation • Inflammatory bowel disease • Dysmotility • Ulcers • Appendicitis • Pancreatitis or pancreatic pseudocyst • Cholelithiasis • Meckel diverticulum or duodenal diverticulum • Mesenteric adenitis • Congenital (fibrous bands, malrotation) • Intermittent intussusception • Pseudo-obstruction • Other causes of bowel obstruction
Psychogenic or psychiatric
	• Conversion disorder • School phobia • Depression • Bulimia • Munchausen syndrome or Munchausen by proxy
Metabolic, endocrine, or renal
	• Acute intermittent porphyria • Aminoacidopathies • Organic acidemias • Urea cycle defects • Pheochromocytoma • Diabetes mellitus • Adrenal insufficiency • Acute hydronephrosis
Infectious or rheumatologic
	• Helicobacter pylori infections • Recurrent urinary tract infections • Giardiasis • Atopic disease with histamine initiation
Toxic ingestions
	• Heavy metals (eg, arsenic)

Diagnostic workup

First-line testing for cyclic vomiting syndrome includes an upper gastrointestinal series to evaluate for malrotation/volvulus. In addition, an abdominal ultrasound to look for hydronephrosis and biliary abnormalities should be performed at baseline and, if normal, repeated during an acute episode (25; 31). In addition, a set of electrolytes should be performed during an attack prior to administration of intravenous fluids.

If the patient has severe abdominal pain and bilious vomiting, which is more worrisome for gallbladder dysfunction, hepatitis, pancreatitis, or strictures/adhesions; these patients should also undergo testing of amylase, lipase, liver function testing, and possibly abdominal CT if ultrasound is unrevealing.

If there are intercurrent symptoms of gastrointestinal dysfunction or significant amount of hematemesis during attacks, endoscopy should be considered to evaluate for celiac disease, allergic esophagitis, or reflux.

In patients where there are signs of intercurrent or attack-related neurologic dysfunction (altered mental status, developmental delay or regression, hypotonia, personality changes, seizures) or attacks precipitated by fasting, protein, or illness, testing should be performed for fatty acid oxidation defects, amino/organic acidopathies, urea cycle defects, and mitochondrial dysfunction. A review by Gelfand and Gallagher outlines the appropriate approach to the workup for inborn errors of metabolism (11).

In children with alteration of mental status, headache, abnormal eye movements, ataxia, papilledema, seizures, or motor asymmetry present, MRI should be considered to look for hydrocephalus or intracranial mass. And in those children with seizures, transient alteration in mental status or other abnormal movements EEG should be performed in the awake and sleep states.

The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition has published a diagnostic flow-chart summarizing the recommended evaluation of a cyclic vomiting pattern in children older than two years of age (20).

Cyclic vomiting pattern evaluation for children older than 2 years

(From: Li BU, Lefevre F, Chelimsky CG, et al. North American society for pediatric gastroenterology, hepatology, and nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroentero...

Management

Standard medical approaches are lacking for cyclic vomiting syndrome, and there is a notable absence of controlled trials and rigorous scientific evidence. There are no medications that are FDA approved for cyclic vomiting. Treatment approaches include strategies for prevention of attacks and then management to abort or treat an attack. The majority of these recommendations are based on the management of migraines.

Prevention of attacks focuses on lifestyle measures that can help reduce triggers. All patients should have a diary that is used to help identify potential preceding events that made a vomiting attack more likely. The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Consensus Task Force concludes that lifestyle changes can significantly reduce episode frequency in children with cyclic vomiting syndrome, despite the lack of published evidence to this effect (20). Table 3 summarizes the recommended lifestyle changes that should be adopted.

Table 3. Lifestyle Changes in Cyclic Vomiting Syndrome (for 1 to 2 months or 1 to 2 cycles)

• Reassurance (eg, episodes are not self-induced) and anticipatory guidance (eg, natural history)
• Avoidance of triggers
	- Keep a "vomiting diary" of potential precipitating factors - Avoid fasting - Recognize the potential role of excitement as a trigger (eg, downplay big events) - Maintain good sleep hygiene (eg, avoid sleep deprivation) - Avoid triggering foods (eg, chocolate, cheese, monosodium glutamate, antigenic foods) - Avoid excessive energy output
• Supplemental carbohydrates for fasting-induced episodes
	- Provide fruit juices, other sugar-containing drinks - Provide extra snacks between meals, before exertion, or at bedtime
• Migraine headache lifestyle interventions
	- Regular aerobic exercise (avoid over-exercising) - Regular meal schedules (ie, avoid skipping meals) - Moderation in consuming or avoidance of caffeine - Preventive supplements and medication should be considered in children where the vomiting attacks occur with frequency (> 1/month) or attacks require frequent or prolonged hospital stays (more than 3 days at a time). The NASPGHN guidelines for preventive medications including dosing are published here. First-line preventive therapy for children under age five years is cyproheptadine and for those over five years is amitriptyline. Amitriptyline continues to show efficacy in pediatric randomized control trials (03; 04). Propranolol can be considered as an alternative treatment in either age group. The American Neurogastroenterology and Motility Society and the Cyclic Vomiting Association published consensus guidelines for management of cyclic vomiting syndrome in adults that mirror the recommendations for pediatrics. Tricyclics with coenzyme q10 is considered first line for moderate to severe cyclic vomiting syndrome (37). An adapted form of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Consensus Task Force guidance on dosing of these medications is as follows (20).

Table 4. Prophylactic Medications

• Children 5 years old or younger:
	- Cyproheptadine 0.25 to 0.5 mg/kg/day divided twice or three times daily can be increased weekly to a total daily dose of 1.5 mg/kg/day divided twice or three times daily
	- Propranolol 0.25 to 1 mg/kg/day divided twice or three times daily can increase every 2 weeks to goal dose of 2 to 4 mg/kg/day divided twice or three times daily
• Children older than 5 years:
	- Amitriptyline begin at 0.25 to 0.5 mg/kg/day given at bedtime, increase weekly by 5 to 10 mg, until 1 to 1.5 mg/kg/day
	- Propranolol as above
• Supplements:
	- Carnitine 50 to 100 mg/kg/day divided twice or three times daily (max 1 g three times a day)
	- Coenzyme Q10 ten mg/kg/day divided twice or three times daily (max 100 mg three times a day)

Treatment of attacks focuses on early recognition and treatment. Migraine medicines, including triptans, have been looked at in aborting attacks and there are case reports of success using sumatriptan either nasal spray or subcutaneously. There is a slight tendency for those with a strong family history of migraine to respond better to triptan medications (13). Antiemetics can certainly help mitigate the symptoms and there are data in the pediatric literature to support the use of the NK-1 receptor antagonist aprepitant for abortive and preventive use (08). Dr. Li, an expert in cyclic vomiting syndrome, added aprepitant in his update to the treatment of cyclic vomiting syndrome in children (21). A retrospective review of the use of aprepitant in adults refractory to other medications showed it to be significantly helpful (28). However, cost of the medication can be prohibitive and limits use. Once the vomiting has begun the best methods of management are supportive, including hydration and sleep induction with analgesia as needed.

In addition, guidelines for treatment for cyclic vomiting syndrome in both adults and children recommend screening for, and addressing, common comorbid conditions in cyclic vomiting syndrome. These conditions include anxiety, depression, migraine, autonomic dysfunction (postural orthostatic tachycardia syndrome), sleep disorders, and substance use (particularly marijuana) (21; 37).

Outcomes

The preventive medicines have been available for many years and generally are considered safe. Cyproheptadine’s biggest issue is sedation and weight gain. Amitriptyline may also induce drowsiness so it should be given at night, and it can trigger cardiac arrhythmias in those that have prolonged QT and other cardiac abnormalities. The recommendation is to do a screening EKG on all patients prior to initiation of amitriptyline to look cardiac arrhythmias. Propranolol is generally well tolerated; however, it can produce bradycardia. Patients taking propranolol should be started on a low dose increased at minimum intervals of every two weeks. Blood pressure and heart rate should be followed closely.

A randomized controlled trial looking at the use of amitriptyline versus cyproheptadine in 64 children with cyclic vomiting syndrome between the ages of 3 and 15 years showed that both medications were effective. Fifty percent of those in the cyproheptadine group had full remission compared to 65.6% in the amitriptyline group (03).

Preventive medicines should reduce the severity and frequency of attacks. Hopefully, emergency room visits will decrease, and more attacks will be managed at home. Patients should be tried on medication for 2 to 3 months minimum before determining its efficacy.

References

01: Abdulkader ZM, Bali N, Vaz K, Yacob D, Di Lorenzo C, Lu PL. Predictors of hospital admission for pediatric cyclic vomiting syndrome. J Pediatr 2021;232:154-8. PMID 33259858
02: Aziz I, Palsson OS, Whitehead WE, Sperber AD, Simrén M, Törnblom H. Epidemiology, clinical characteristics, and associations for Rome IV functional nausea and vomiting disorders in adults. Clin Gastroenterol Hepatol 2019;17(5):878-86. PMID 29857155
03: Badihian N, Saneian H, Badihian S, Yaghini O. Prophylactic therapy of cyclic vomiting syndrome in children: comparison of amitriptyline and cyproheptadine: a randomized clinical trial. Am J Gastroenterol 2018;113(1):135-40. PMID 28719594
04: Bagherian Z, Yaghini O, Saneian H, Badihian S. Comparison of the efficacy of amitriptyline and topiramate in prophylaxis of cyclic vomiting syndrome. Iran J Child Neurol 2019;13(1):37-44. PMID 30613204
05: Bar O, Ebenau L, Weiner K, Mintz M, Boles RG. Whole exome/genome sequencing in cyclic vomiting syndrome reveals multiple candidate genes, suggesting a model of elevated intracellular cations and mitochondrial dysfunction. Front Neurol 2023;14:1151835. PMID 37234784
06: Bhandari S, Venkatesan T. Clinical characteristics, comorbidities and hospital outcomes in hospitalizations with cyclic vomiting syndrome: a nationwide analysis. Dig Dis Sci 2017;62(8):2035-44. PMID 28050780
07: Boles RG, Williams JC. Mitochondrial disease and cyclic vomiting syndrome. Dig Dis Sci 1999;44(8):103S-7S. PMID 10490048
08: Cristofori F, Thapar N, Saliakellis E, et al. Efficacy of the neurokinin‐1 receptor antagonist aprepitant in children with cyclical vomiting syndrome. Aliment Pharmacol Ther 2014;40(3):309-17. PMID 24898244
09: Drumm BR, Bourke B, Drummond J, et al. Cyclical vomiting syndrome in children: a prospective study. Neurogastroenterol Motil 2012;24(10):922-7. PMID 22762244
10: Ellingsen DM, Garcia RG, Lee J, et al. Cyclic vomiting syndrome is characterized by altered functional brain connectivity of the insular cortex: A cross-comparison with migraine and healthy adults. Neurogastroenterol Motil 2017;29(6). PMID 27910222
11: Gelfand A, Gallagher R. Cyclic vomiting syndrome versus inborn errors of metabolism: a review with clinical recommendations. Headache 2016;56(1):215-21.** PMID 26678622
12: Gosalvez-Tejada A, Li BUK, Simpson P, Zhang L, Kovacic K. Natural history of pediatric cyclic vomiting syndrome: progression to dysautonomia. J Pediatr Gastroenterol Nutr 2023;76(6):737-42. PMID 36800281
13: Hikita T, Kodama H, Kaneko S, et al. Sumatriptan as treatment for cyclic vomiting syndrome: a clinical trial. Cephalalgia 2011;31(4):504-7. PMID 21147834
14: Hikita T, Kodoma H, Ogita K, Kaneko S, Nakamoto N, Mimaki M. Cyclic vomiting syndrome in infants and children: a clinical follow-up study. Pediatric Neurology 2016;57:29-33. PMID 26861170
15: Kovacic K, Sood M, Venkatesan T. Cyclic vomiting syndrome in children and adults: what is new in 2018? Curr Gastroenterol Rep 2018;20(10):46. PMID 30159612
16: Kumar N, Bashar Q, Reddy N, Sengupta J, Ananthakrishnan A, Schroeder A, Hogan WJ, Venkatesan T. Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms--pediatric versus adult? BMC Gastroenterol 2012;12-52. PMID 22639867
17: Lagman-Bartolome AM, Lay C. Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome. Curr Neurol Neurosci Rep 2015;15(6):34. PMID 25903296
18: Lee J, Wong SA, Li BU, Boles RG. NextGen nuclear DNA sequencing in cyclic vomiting syndrome reveals a significant association with the stress-induced calcium channel (RYR2). Neurogastroenterol Motil 2015;27(7):990-6. PMID 25925909
19: Li BU, Balint JP. Cyclic vomiting syndrome: evolution in our understanding of a brain-gut disorder. Adv Pediatr 2000;47:117-60. PMID 10959442
20: Li BU, Lefevre F, Chelimsky CG, et al. North American society for pediatric gastroenterology, hepatology, and nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr 2008;47:379-93. PMID 18728540
21: Li BUK. Managing cyclic vomiting syndrome in children: beyond the guidelines. Eur J Pediatr 2018;177(10):1435-42.** PMID 30076469
22: Lin YP, Ni YH, Weng WC, Lee WT. Cyclic vomiting syndrome and migraine in children. J Formos Med Assoc 2011;110(6):382-7. PMID 21741006
23: Lucia-Casadonte CJ, Whaley KG, Chogle AS. Yield and costs of evaluating children with cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr 2018;67(1):13-17. PMID 29373437
24: Moavero R, Papetti L, Bernucci MC, et al. Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: a longitudinal study. Cephalalgia 2019; 39(10):1236-40. PMID 30982347
25: Moses J, Keilman A, Worley S, Radhakrishnan K, Rothner AD, Parikh S. Approach to the diagnosis and treatment of cyclic vomiting syndrome: a large single-center experience with 106 patients. Pediatr Neurol 2014;50(6):569-73.** PMID 24842256
26: Panayiotopoulos CP, Michael M, Sanders S, Valeta T, Koutroumanidis M. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain 2008;131(Pt 9):2264-86. PMID 18718967
27: Parker LA, Rock EM, Limebeer CL. Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol 2011;163(7):1411-22. PMID 21175589
28: Patel M, Partovi O, Mooers H, Kovacic K, Garacchi Z, Venkatesan T. Efficacy of aprepitant as a prophylactic medication in adults with cyclic vomiting syndrome. Neurogastroenterol Motil 2023;35(4):e14530. PMID 36740813
29: Rashed H, Abell TL, Familoni BO, Cardoso S. Autonomic function in cyclic vomiting syndrome and classic migraine. Dig Dis Sci 1999;44(8 Suppl):74S-78S. PMID 10490043
30: Redon S, Mareau C, Guedj E, Donnet A. Cyclic vomiting syndrome in adults and children: a hypothesis. Headache 2017;57(6):943-51. PMID:28488756
31: Rosman P, Dutt M, Nguyen HT. A curable and probably often overlooked cause of cyclic vomiting syndrome. Semin Pediatr Neurol 2014;21:60-5. PMID 25149923
32: Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc 2012;87(2):114-9. PMID 22305024
33: Stanghellini V, Chan, FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology 2016;150(6):1380‐92. PMID 27147122
34: To J, Issenman RM, Kamath MV. Evaluation of neurocardiac signals in pediatric patients with cyclic vomiting syndrome through power spectral analysis of heart rate variability. J Pediatr 1999;135(3):363-6. PMID 10484804
35: Venkatesan T, Prieto T, Barboi A. Autonomic nerve function in adults with cyclic vomiting syndrome: a prospective study. Neurogastroenterol Motil 2010a;22(12):1303-7, e339. PMID 20667005
36: Venkatesan T, Hillard CJ, Rein L, Banerjee A, Lisdahl K. Patterns of cannabis use in patients with cyclic vomiting syndrome. Clin Gastroenterol Hepatol 2020;18(5):1082-90. PMID 31352091
37: Venkatesan T, Levinthal DJ, Tarbell SE, et al. Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association. Neurogastroenterol Motil 2019;31 Suppl 2:e13604.** PMID 31241819
38: Venkatesan T, Zadvornova Y, Raff H, Hillard CJ. Endocannabinoid-related lipids are increased during an episode of cyclic vomiting syndrome. Neurogastroenterol Motil 2016;28(9):1409-18. PMID 27098832
39: Venkatesan T, Zaki EA, Kumar N, et al. Quantitative pedigree analysis and mitochondrial DNA sequence variants in adults with cyclic vomiting syndrome. BMC Gastroenterol 2014;14:181. PMID 25332060
40: Wasilewski A, Lewandowska U, Mosinska P, et al. Cannabinoid receptor type 1 and mu-opioid receptor polymorphisms are associated with cyclic vomiting syndrome. Am J Gastroenterol 2017;112(6):933-9. PMID 28349993
41: Zaki EA, Freilinger T, Klopstock T, et al. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia 2009;29(7):719-28. PMID 19220304

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Shannon Babineau MD

Dr. Babineau of Goryeb Children’s Hospital has no relevant financial relationships to disclose.
See Profile

Editor

Bernard L Maria MD

Dr. Maria of Thomas Jefferson University has no relevant financial relationships to disclose.
See Profile

Former Authors

Jong M Rho MD

Patient Profile

Age range of presentation: 1 month to 65+ years
Sex preponderance: Female > male
Heredity: Heredity may be a factor

In some population of patients maternal inheritance is more common
Population groups selectively affected: Caucasians seem to be selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-9: Cyclic vomiting syndrome: 536.2
ICD-10: Cyclic vomiting syndrome: G43.82
OMIM: Cyclic vomiting syndrome including CVS plus: #500007

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Cyclic vomiting syndrome

Associated Disorders

Abdominal migraine
Autonomic dysfunction including POTS
Benign paroxysmal torticollis of infancy
Benign paroxysmal vertigo of childhood
Migraine without aura
- Migraine with aura
- Motion sickness

Differential Diagnosis

abdominal migraine
acute hydronephrosis
acute intermittent porphyria
adrenal insufficiency
aminoacidopathies
- appendicitis
- atopic disease with histamine initiation
- cannabinoid hyperemesis syndrome
- CNS neoplasms (brainstem gliomas, temporal lobe astrocytomas)
- complex partial seizures (Panayiotopoulos syndrome)
- congenital (fibrous bands, malrotation)
- constipation
- conversion disorder
- depression
- diabetes mellitus
- dysmotility
- familial dysautonomia
- gastroesophageal reflux
- giardiasis
- heavy metals (ie, arsenic)
- helicobacter pylori infections
- hydrocephalus
- inflammatory bowel disease
- intermittent intussusception
- ion channelopathy
- irritable bowel syndrome
- lactose intolerance
- Meckel diverticulum or duodenal diverticulum
- mesenteric adenitis
- mitochondrial disease
- Munchausen syndrome or Munchausen by proxy
- organic acidemias
- other causes of bowel obstruction
- pancreatitis or pancreatic pseudocyst
- Panayiotopoulos syndrome
- pheochromocytoma
- recurrent urinary tract infections
- school phobia
- subdural hematomas or effusions
- ulcers
- urea cycle defects

Also Relevant

Abdominal migraine
Benign paroxysmal vertigo
Childhood migraine
Nausea and vomiting
Panayiotopoulos syndrome

Cyclic vomiting syndrome

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Table 1. Diagnostic Criteria of Cyclic Vomiting Syndrome*

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Table 2. Differential Diagnosis of Cyclic Vomiting Syndrome

Diagnostic workup

Management

Table 3. Lifestyle Changes in Cyclic Vomiting Syndrome (for 1 to 2 months or 1 to 2 cycles)

Table 4. Prophylactic Medications

Outcomes

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Breath-holding spells

Acute cerebellar ataxia in children

Headache in children: overview and treatment approaches

Alternating hemiplegia of childhood

Pyridoxine/P5P-dependent developmental epileptic encephalopathy

Zika virus: neurologic complications

Cerebral edema in childhood

This is an article preview.
Start a Free Account
to access the full version.